期刊文献+

利维爱治疗绝经期泌尿生殖症状的90例临床观察 被引量:12

利维爱治疗绝经期泌尿生殖症状的90例临床观察
暂未订购
导出
摘要 目的观察利维爱(lival)治疗围绝经期妇女泌尿生殖道症状的疗效。方法将90例绝经一年的具有泌尿生殖症状的门诊病人随机分成两组。A组,安慰剂糖丸组;B组,利维爱2.5mg/日组。观察12个月后AB两组的泌尿生殖道症状改善情况及阴道细胞学检查情况。结果通过χ2检验两组治疗有显著的统计差异。结论利维爱可有效改善绝经期妇女的泌尿生殖道症状且副作用较少。 Objective Observing the result of applying Lival treating climacteric women with urinary and reproductive tunnel symptoms. Method Dividing 90 cases of woman outpatients being with the urinary and reproductive (tunnel) symptoms one year after their menopause into two groups. Feeding with Group A: consoling sugar pills; Group B: Lival, 2.5mg/day Target observed improvement of the urinary and reproductive tunnel symptoms and cytological examination results on vaginae for each group of patients after 12 months. Result there is an outstanding statistical difference on X2 examination results between the two groups. Conclusion Lival can effectively improve the urinary and reproductive tunnel symptoms for climacteric women while its side effects are very limited.
出处 《国际医药卫生导报》 2006年第4期42-43,共2页 International Medicine and Health Guidance News
关键词 利维爱 安慰剂糖丸 泌尿生殖道症状 Lival Consoling sugar pill urinary and reproductive tunnel symptom.
  • 相关文献

参考文献3

二级参考文献20

  • 1Hanifi-Moghaddam P, Gielen SC, Kloosterboer H J, et al. Molecular portrait of the progestagenic and estrogenic actions of tibolone: be havior of cellular networks in response to tibolone. J Clin Endocrinol Metab, 2005, 90(1): 973-983.
  • 2Moore RA. Livial: a review of clinical studies. Br J Obstet Gynaecol,i999,106 [Suppl 19]:1-21.
  • 3Sperfff L, Clarkson T. Is Tibilone a vilable arternative to HT ? Cont Obstet Gynecol, 2003, 48( 1):54-68.
  • 4Landgren MB, Coelingh H J, Helmond FA, et al. Dose-response analysis of effects of tibolone on climacteric symptoms. BJOG, 2002,109(10):1109-1114.
  • 5Gallagher JC, Baylink DJ, Freeman R, et al. Prevention of bone loss with tibolone in postmenopausal women: Results of two randomized,double-blind, placebo-control, dose-finding studies. J Clin Endocrinol Metab, 2001,86(10):4717-4726.
  • 6Huber J, Palacios S, Berglund L, et al. Effects of tibilone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women. B JOG,2002,109(8):886-893.
  • 7Morris EP, Wilson PO, Robinson J, et al. Long term effects of tibilone on the genital tract in postmenopausal women. Br J Obstet Gynaecol,1999, 106(9): 954-959.
  • 8Fenkci V, Yilmazer M, Fenkci S. Effects of short-time (3 months) tibilone on bone turnover in postmenopausal women. Arch Gynecol Obstet, 2003, 268(8): 85-87.
  • 9Ederveen AG, Klooster HJ. Tibolone exerts an estrogenic effect on bone leading to preventiom of bone loss and reduction in bone resorption in ovariectomized rats. Osteoporosis Int, 1998,8[Suppl]:293.
  • 10Koh KK, Ahn JY, Kyu D, et al. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomoized, double-blind, placebocontrolled, crossover study. Arterioscler Thromb Vasc Biol, 2003, 23(8): 1889-1894.

共引文献150

同被引文献66

引证文献12

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部